Wealth Enhancement Advisory Services, LLC Aura Biosciences, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $55.6 Billion
- Q2 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 11,853 shares of AURA stock, worth $70,999. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,853
Previous 15,437
23.22%
Holding current value
$70,999
Previous $90,000
17.78%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding AURA
# of Institutions
106Shares Held
51.6MCall Options Held
0Put Options Held
0-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$41.5 Million22.54% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA5.1MShares$30.5 Million1.68% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.88MShares$29.2 Million0.05% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR4.62MShares$27.7 Million1.33% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.37MShares$26.2 Million0.94% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $175M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...